极低/低危与中/高危前列腺癌男性主动监测的中期结局比较
该研究比较了635例局限性前列腺癌男性中有利风险与中/高危风险患者接受主动监测的中期结局,中位随访50.5个月(IQR 31.1-80.3)。中/高危患者117例(18.4%),与有利风险患者相比在转移、监测失败或治愈性干预方面无差异,但全因死亡风险显著增加,可能反映患者选择因素。
要点
- 635例局限性前列腺癌主动监测,中位随访50.5个月(IQR 31.1-80.3),中/高危占18.4%(117例)。
- 5年和10年总生存分别为98%和94%,无转移生存分别为99%和98%,未观察到前列腺癌特异性死亡。
- 中/高危与有利风险患者在转移、监测失败或治愈性干预方面无差异,但全因死亡风险显著增加。
核心结论
- 接受主动监测的局限性前列腺癌患者无论基线风险如何,主动监测失败率、前列腺癌特异性死亡和转移率均低。
研究设计与样本
- 2002年起在美国一家高容量学术医院接受主动监测的635例局限性前列腺癌男性,中位随访50.5个月(IQR 31.1-80.3),进行时间至事件分析。
主要发现
- 117例(18.4%)为中/高危疾病。
- 总体5年和10年全因生存分别为98%和94%。
- 5年和10年累积无转移生存分别为99%和98%,至今未观察到前列腺癌特异性死亡。
- 总体免于干预率5年和10年分别为61%和49%。
- 总体累积免于主动监测失败(定义为转移或治愈性局部治疗后的生化失败)5年和10年分别为97%和91%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 结论可能受事件数少和研究持续时间限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We compare intermediate term clinical outcomes among men with favorable risk and intermediate/high risk prostate cancer managed by active surveillance. MATERIALS AND METHODS: A total of 635 men with localized prostate cancer have been on active surveillance since 2002 at a high volume academic hospital in the United States. Median followup is 50.5 months (IQR 31.1-80.3). Time to event analysis was performed for our clinical end points. RESULTS: Of the cohort 117 men (18.4%) had intermediate/high risk disease. Overall 5 and 10-year all cause survival was 98% and 94%, respectively. Cumulative metastasis-free survival at 5 and 10 years was 99% and 98%, respectively. To date no cancer specific deaths had been observed. Overall freedom from intervention was 61% and 49% at 5 and 10 years, respectively. Overall cumulative freedom from failure of active surveillance, defined as metastasis or biochemical failure after local therapy with curative intent, was 97% and 91% at 5 and 10 years, respectively. Of the men 21 (9.9%) experienced biochemical failure after deferred treatment and the 5-year progression-free probability was 92%. Compared to men with favorable risk disease those with intermediate/high risk cancer experienced no difference in metastases, surveillance failure or curative intervention. However, patients at higher risk were at significantly increased risk for all cause mortality, likely reflecting patient selection factors. These conclusions may be limited by the small number of events and the duration of our study. CONCLUSIONS: Patients with localized prostate cancer who are on active surveillance demonstrated a low rate of active surveillance failure, prostate cancer specific mortality and metastases regardless of baseline risk.
引用
- Nyame YA, Almassi N, Haywood SC, et al. Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance. J Urol. 2017. PMID: 28347770. doi:10.1016/j.juro.2017.03.123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。